Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
NCT03886506
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Critical Limb Ischemia (CLI)
Interventions
BIOLOGICAL:
PLX-PAD
Sponsor
Pluristem Ltd.